Clinical Trials Logo

Clinical Trial Summary

The aim is to compare effective growth true hypoplastic pulmonary arteries using Right Ventricle Outflow Tract Reconstruction by femoral allogenic vein valve conduit and systemic-to-pulmonary artery shunts (modified Blalock-Taussig shunt)


Clinical Trial Description

The use of femoral allogenic vein valve conduit for Right Ventricle Outflow Tract Reconstruction is good alternative systemic-to-pulmonary artery shunts (modified Blalock-Taussig shunt). Main advantages is straight, symmetrical, pulsating, systolic blood flow in hypoplastic pulmonary artery, which stimulate growth and prepares for a radical repair. Taking into account the absence randomized studies in this area of medicine, providing investigation evaluating parameters of safety for both methodics is very actual. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02861963
Study type Interventional
Source Meshalkin Research Institute of Pathology of Circulation
Contact
Status Completed
Phase N/A
Start date May 5, 2016
Completion date November 22, 2019

See also
  Status Clinical Trial Phase
Completed NCT04452188 - Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period N/A